Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tumor necrosis factor blockers and reactivation of latent tuberculosis.

× No keyword cloud information.

15 in total

Review 1. Latent tuberculosis: what the host "sees"?

Authors: Hannah P Gideon; JoAnne L Flynn
Journal: Immunol Res Date: 2011-08 Impact factor: 2.829

2. Comparison of tuberculosis incidence in ankylosing spondylitis and rheumatoid arthritis during tumor necrosis factor inhibitor treatment in an intermediate burden area.

Authors: Hye Won Kim; Jin Kyun Park; Ji-Ae Yang; Young Im Yoon; Eun Young Lee; Yeong Wook Song; Hang Rae Kim; Eun Bong Lee
Journal: Clin Rheumatol Date: 2013-09-22 Impact factor: 2.980

3. Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques.

Authors: Philana Ling Lin; Veronique Dartois; Paul J Johnston; Christopher Janssen; Laura Via; Michael B Goodwin; Edwin Klein; Clifton E Barry; Joanne L Flynn
Journal: Proc Natl Acad Sci U S A Date: 2012-07-23 Impact factor: 11.205

Review 4. Understanding latent tuberculosis: a moving target.

Authors: Philana Ling Lin; Joanne L Flynn
Journal: J Immunol Date: 2010-07-01 Impact factor: 5.422

Review 5. Persistent high mortality in advanced HIV/TB despite appropriate antiretroviral and antitubercular therapy: an emerging challenge.

Authors: Gregory P Bisson; Nicola Zetola; Ronald G Collman
Journal: Curr HIV/AIDS Rep Date: 2015-03 Impact factor: 5.071

Review 6. Tuberculosis: global approaches to a global disease.

Authors: Denise E Kirschner; Douglas Young; JoAnne L Flynn
Journal: Curr Opin Biotechnol Date: 2010-07-14 Impact factor: 9.740

Review 7. Modeling tuberculosis in nonhuman primates.

Authors: Charles A Scanga; JoAnne L Flynn
Journal: Cold Spring Harb Perspect Med Date: 2014-09-11 Impact factor: 6.915

8. Mycobacterial pulmonary infections in patients with idiopathic pulmonary fibrosis.

Authors: Sung-Woo Park; Jin Woo Song; Tae Sun Shim; Moo-Suk Park; Hong-Lyeol Lee; Soo-Taek Uh; Choon-Sik Park; Dong Soon Kim
Journal: J Korean Med Sci Date: 2012-07-25 Impact factor: 2.153

9. Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).

Authors: W G Dixon; K L Hyrich; K D Watson; M Lunt; J Galloway; A Ustianowski; D P M Symmons
Journal: Ann Rheum Dis Date: 2009-10-22 Impact factor: 19.103

10. Reduction of chemokine secretion in response to mycobacteria in infliximab-treated patients.

Authors: Sandra M Newton; Sarah L Mackie; Adrian R Martineau; Katalin A Wilkinson; Beate Kampmann; Corinne Fisher; Shouma Dutta; Michael Levin; Robert J Wilkinson; Geoffrey Pasvol
Journal: Clin Vaccine Immunol Date: 2007-12-26